Skip to content

Bedside Renal Ultrasound Assessment in Patients With Acute Kidney Injury

Bedside Renal Ultrasound Assessment in Critically Ill Patients With Acute Kidney Injury: an Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06156098
Enrollment
100
Registered
2023-12-05
Start date
2023-09-01
Completion date
2024-09-30
Last updated
2024-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness

Keywords

Critical Illness, Ultrasound Therapy, Kidney injury

Brief summary

Exploring the predictive and evaluative value of various indicators of bedside critical renal ultrasound in critically ill patients with acute kidney injury (AKI)

Detailed description

This study aims to perform bedside renal ultrasound examinations on critically ill patients admitted to the ICU (including sepsis, respiratory failure, shock, multiple trauma, etc.) and prospectively observe the relationship between ultrasound parameters and the occurrence and progression of AKI, in conjunction with traditional renal function indicators. This will provide clinicians with a rapid, non-invasive, and visual examination tool at the bedside for early diagnosis and treatment of AKI.

Interventions

OTHERNo Intervention

No Intervention

Sponsors

Qin Zhang
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years

Inclusion criteria

* Age ≥ 18 years and ≤ 70 years * Criteria for sepsis patients

Exclusion criteria

* Pregnant women. * Patients with malignant tumors, severe heart failure, chronic renal insufficiency, end stage renal disease, kidney transplantation.

Design outcomes

Primary

MeasureTime frameDescription
Survival28 days28-day mortality rate

Secondary

MeasureTime frameDescription
AKI28 daysduration of continuous renal replacement therapy (CRRT)during hospitalization, length of hospital stay, duration of ICU stay, hospital mortality rate, 28-day mortality rate, and other relevant data.

Countries

China

Contacts

Primary ContactXiao Zhang, phd
ranxiao1001@tjh.tjmu.edu.cn15926207366
Backup ContactQin Zhang, phd
qzhang8@tjh.tjmu.edu.cn15717154768

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026